Diagnostic substrate error in medical testing device causes test failures
bioMerieux is recalling 1,579 VIDAS DEX@ diagnostic devices due to substrate errors that prevent test execution, requiring users to rerun tests and potentially delaying results.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II device recall with a functional defect (substrate error) that prevents test execution. No illnesses, injuries, or hospitalizations are reported. The impact is operational—requiring users to rerun tests and potentially delaying results—rather than a direct safety hazard.
Plain-English summary
bioMerieux, Inc. is recalling 1,579 VIDAS DEX@ (Dimer Exclusion II) diagnostic devices with nationwide U.S. distribution. The devices are recalled due to a substrate error that prevents the test from being run.
When this error occurs, the user must run another test, which can lead to delayed test results. bioMerieux has been receiving an increasing number of complaints related to this substrate error.
The recalled lot numbers are 1008696660, 1008761020, 1008864290, and 1008891690. The device UDI is 03573026387006, REF 30455-01.
The recalled product
- Product
- VIDAS DEX@, Dimer Exclusion II, REF 30455-01
- Manufacturer
- bioMerieux, Inc.
- Affected units
- 1,579
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- UDI 03573026387006
- Lot #s: 1008696660
- 1008761020
- 1008864290
- 1008891690
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by bioMerieux, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · bioMerieux, Inc.
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · substrate error
See all →- ModerateFDA Recalls VIDAS PRG Progesterone Test Kits for Substrate Error
FDA (Devices) · 2022-01-05
- HighVIDAS procalcitonin diagnostic test substrate error causes testing delays
FDA (Devices) · 2022-01-05
- HighVIDAS Mumps IgG diagnostic test kit recalled due to substrate error
FDA (Devices) · 2022-01-05
- ModerateVIDAS LH diagnostic test substrate error causes delayed results
FDA (Devices) · 2022-01-05
- HighVIDAS SARS-COV-2 Diagnostic Test Recalled for Substrate Error
FDA (Devices) · 2022-01-05